Delivery Order 36F79718D0414-36C77020N0117
Award Date
6/9/20
Potential Completion Date
6/15/20
Potential Value
$580K
Funding Federal Agency
Veterans Integrated Service Network 12
Contracting Federal Agency
Veterans Integrated Service Network 15
Awardee
Neurocrine Biosciences, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92130, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded a $840,641 delivery order to Neurocrine Biosciences, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The contract calls for Neurocrine to provide VALBENAZINE to Veterans Integrated Service Network 12 in support of VA-VHA programs. Performance will take place in San Diego, California over a period of one week from January 3-10, 2020. The firm fixed price contract utilizes Neurocrine's existing...
The Department of Veterans Affairs Veterans Health Administration awarded a $543,648 delivery order to Neurocrine Biosciences, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The contract calls for Neurocrine to provide VALBENAZINE 80MG capsules to Veterans Integrated Service Network 12 in support of VA-VHA programs. Performance will take place in San Diego, California over a period of four days from September 22 to September 25, 2020. The firm fixed price contract...
The Department of Veterans Affairs Veterans Health Administration awarded a $677,821.50 delivery order contract to Neurocrine Biosciences, Inc. to supply the pharmaceutical products VALBENAZINE, NDC 70370-1080-01 and 70370-2040-01. The contract was issued against Neurocrine's GSA Schedule Pharmaceuticals and Drugs listing under the Federal Supply Schedule contract number FSS-61-IB. Performance will take place in San Diego, California over an approximately one week period concluding on October 7,...
The Department of Veterans Affairs Veterans Health Administration awarded a $536,349 delivery order to Neurocrine Biosciences, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The order calls for Neurocrine to provide the drug valbenazine to VHA facilities in San Diego, California from February 27 to March 3, 2020. Valbenazine will support VHA's efforts to treat veterans through its Veterans Integrated Service Network 12 program. As a firm fixed price order placed...
The Department of Veterans Affairs Veterans Health Administration awarded a $676,204.80 firm fixed price delivery order to Neurocrine Biosciences, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The contract calls for Neurocrine to provide valbenazine to Veterans Integrated Service Network 12 in support of the VA-VHA's healthcare programs. Performance will take place in San Diego, California over a period of four days from October 8-12, 2020. No subcontractors or set...
The Department of Veterans Affairs Veterans Health Administration awarded a $652,376 delivery order to Neurocrine Biosciences, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The order calls for the delivery of VALBENAZINE 80MG capsules to the Hines VA Medical Center in Illinois. The one-week period of performance from November 3 to November 10, 2020 indicates this was likely an urgent order to treat veterans for a condition addressed by the medication. Neurocrine...
The Department of Veterans Affairs Veterans Health Administration awarded a $677,821.50 firm fixed price delivery order against the prime contractor Neurocrine Biosciences, Inc.'s Pharmaceuticals and Drugs GSA Schedule. This order is for the delivery of VALBENAZINE 80MG and 40MG oral capsules to facilities within Veterans Integrated Service Network 12. Neurocrine Biosciences will deliver the requested medications from its production location in San Diego, California by July 6, 2021 to support...
This federal contract award to Neurocrine Biosciences, Inc. is for the pharmaceutical product VALBENAZINE capsules, which are used to treat neurological movement disorders. The contract, valued at $468,217.20, was awarded by the Department of Veterans Affairs Veterans Health Administration's Veterans Integrated Service Network 12 and is a firm fixed price delivery order against Neurocrine's General Services Administration (GSA) Multiple Award Schedule contract for Pharmaceuticals and Drugs....
The Department of Veterans Affairs Veterans Health Administration awarded a $576,116 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Neurocrine Biosciences, Inc. to provide valbenazine. The contract has a period of performance from March 26, 2020 through April 1, 2020 for product delivery to a location in San Diego, California. Valbenazine will support the VA-VHA's mission to provide healthcare services to veterans through its Veterans Integrated Service Network...
The Department of Veterans Affairs Veterans Health Administration awarded Neurocrine Biosciences, Inc. a $630,480.96 firm fixed price delivery order against the company's GSA Schedule contract for Pharmaceuticals and Drugs. The contract will provide pharmaceutical products to support VHA operations within Veterans Integrated Service Network 9, with performance taking place in San Diego, California from November 19-24, 2020. No set-aside designation or subcontractors were indicated. The...